Uplizna

Product manufactured by Viela Bio, Inc.

Application Nr Approved Date Route Status External Links
BLA761142 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Uplizna Is Indicated For The Treatment Of Neuromyelitis Optica Spectrum Disorder (Nmosd) In Adult Patients Who Are Anti-Aquaporin-4 (Aqp4) Antibody Positive. Uplizna Is A Cd19-Directed Cytolytic Antibody Indicated For The Treatment Of Neuromyelitis Optica Spectrum Disorder (Nmosd) In Adult Patients Who Are Anti-Aquaporin-4 (Aqp4) Antibody Positive. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Inebilizumab

Comments